Cystic fibrosis is caused by mutations in the gene encoding the cystic fibrosis transmembrane conductance regulator (CFTR). CFTR is a plasma membrane C1-channel regulated by phosphorylation. Phosphorylation of four serine residues in the R domain by CAMP-dependent protein kinase activates the channels. Phosphorylation-dependent activation is reversible through the action of an as yet unidentified protein phosphatase. Protein kinase C also activates the CFTR C1- channel, but stimulates less current than does PKA. In this study, we will use electrophysiological and biochemical tools to understand how phosphorylation and dephosphorylation regulate CFTR. First, to learn how CAMP-dependent protein kinase activates the CFTR C1- channel, we will use the single-channel patch-clamp technique to compare the activity of wild- type and mutant CFTR C1- channels. We will study the effect of mutating each of the four phosphorylatable serine residues on the single channel open probability and on channel open and closed lifetimes. This work will help us determine how each serine residue contributes to CFTR C1- channel regulation. Second, to learn how phosphorylation by protein kinase C activates the CFTR C1-channel, and why it has an effect different from PKA, we will use th single channel patch-clamp technique and phosphopeptide mapping to determine which PKC phosphorylation sites are responsible for channel activation. Finally, we will identify the epithelial phosphatase that dephosphorylates and inactivates CFTR C1- channels. We will purify the enzyme from epithelial cells, and study its function and regulation. The results of these studies will provide us with new knowledge, at the molecular level, of how CFTR C1- channels are controlled, and hence, how transepithelial C1-secretion is regulated.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Specialized Center (P50)
Project #
5P50HL042385-10
Application #
6109997
Study Section
Project Start
1997-09-01
Project End
1999-08-31
Budget Start
Budget End
Support Year
10
Fiscal Year
1997
Total Cost
Indirect Cost
Name
University of Iowa
Department
Type
DUNS #
041294109
City
Iowa City
State
IA
Country
United States
Zip Code
52242
Graham, Scott M; Scott, Shaun N; Launspach, Janice et al. (2002) The effects of fluticasone propionate on nasal epithelial potential difference. Am J Rhinol 16:145-9
Welsh, Michael J; Price, Margaret P; Xie, Jinghui (2002) Biochemical basis of touch perception: mechanosensory function of degenerin/epithelial Na+ channels. J Biol Chem 277:2369-72
Sawai, M V; Jia, H P; Liu, L et al. (2001) The NMR structure of human beta-defensin-2 reveals a novel alpha-helical segment. Biochemistry 40:3810-6
Prince, L S; Karp, P H; Moninger, T O et al. (2001) KGF alters gene expression in human airway epithelia: potential regulation of the inflammatory response. Physiol Genomics 6:81-9
Ostedgaard, L S; Baldursson, O; Welsh, M J (2001) Regulation of the cystic fibrosis transmembrane conductance regulator Cl- channel by its R domain. J Biol Chem 276:7689-92
Zabner, J; Seiler, M P; Launspach, J L et al. (2000) The osmolyte xylitol reduces the salt concentration of airway surface liquid and may enhance bacterial killing. Proc Natl Acad Sci U S A 97:11614-9
Jepsen, M; Graham, S; Karp, P H et al. (2000) Effect of topical nasal pharmaceuticals on sodium and chloride transport by human airway epithelia. Am J Rhinol 14:405-9
Ostedgaard, L S; Zeiher, B; Welsh, M J (1999) Processing of CFTR bearing the P574H mutation differs from wild-type and deltaF508-CFTR. J Cell Sci 112 ( Pt 13):2091-8
Cotten, J F; Welsh, M J (1999) Cystic fibrosis-associated mutations at arginine 347 alter the pore architecture of CFTR. Evidence for disruption of a salt bridge. J Biol Chem 274:5429-35
McCray Jr, P B; Zabner, J; Jia, H P et al. (1999) Efficient killing of inhaled bacteria in DeltaF508 mice: role of airway surface liquid composition. Am J Physiol 277:L183-90

Showing the most recent 10 out of 61 publications